Global Circulating Tumor Cells Market Size, Status and Forecast 2025

The Circulating Tumor Cells Market Research report clarifies the past experience and trends, on the basis of these past experiences, it offers the future prediction considering other factors influencing the growth rate. This worldwide report offers the detailed analysis of the important factors such as market dynamics (DROT), PEST, and PORTER which assists the growth of the Circulating Tumor Cells Industry. These past experience and factors assist to build the strategy and future planning of Circulating Tumor Cells Market and hold a place in the competitive world.

The Circulating Tumor Cells industry Market report offers the competitive scenario in the Circulating Tumor Cells industry based on the type of product, applications, and the companies that are present in the Circulating Tumor Cells market, and covers the company profiles, their development policies, lined up products and recent launched along with the SWOT analysis of companies.

To get a complete report sample from this link:

This report studies the global Circulating Tumor Cells market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Circulating Tumor Cells market by companies, region, type and end-use industry.

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

The classification of Circulating Tumor Cells (CTCs) products includes CTC enrichment, CTC detection and CTC analysis, and the revenue proportion of CTC enrichment in 2016 is about 43.74%.

North America is the largest supplier of CTCs Products, with a revenue market share nearly 53.18% in 2016. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 28.01% in 2016.

Growth of the global CTCs market is mainly driven by increasing prevalence of cancer globally. Increasing prevalence of various cancers such as breast cancer, prostate cancer and lung cancer is expected to drive growth of the CTCs test market over the forecast period.

FDA approvals for various non-invasive diagnostic tests to detect cancer are set to define the regulatory landscape for CTCs tests. Companies in the CTCs market space are expected to invest more on test kits and cost containment procedures to provide innovative diagnostic solutions to the oncologists and physicians for detecting metastasis.

In 2017, the global Circulating Tumor Cells market size was 1220 million US$ and it is expected to reach 3560 million US$ by the end of 2025, with a CAGR of 14.3% during 2018-2025.

This report focuses on the global top players, covered

Menarini-Silicon Biosystems


Clearbridge Biomedics




Greiner Bio-one GmbH

Advanced Cell Diagnostics

Aviva Biosciences

Fluxion Biosciences

Sysmex Corporation

Epic Sciences




Vortex BioSciences





Market segment by Regions/Countries, this report covers

United States




Southeast Asia


Market segment by Type, the product can be split into

CTC Enrichment

CTC Detection

CTC Analysis

Market segment by Application, split into

Breast Cancer

Prostate Cancer

Colorectal Cancer


The study objectives of this report are:

To study and analyze the global Circulating Tumor Cells market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

To understand the structure of Circulating Tumor Cells market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Circulating Tumor Cells manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Circulating Tumor Cells with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Circulating Tumor Cells submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Contact Details:

Company Name: QYResearch CO.,LIMITED | focus on Market Survey and Research

Tina| Sales Managers

Tel: 0086-20-22093278(CN)

Email: or




Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.